Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07689162 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Liposomal Bupivacaine vs Standard Bupivacaine for Post-Rhinoplasty Analgesia

Name: Liposomal Bupivacaine vs Standard Bupivacaine for Post-Rhinoplasty Analgesia — clinical trial record (NCT07689162)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 2

SponsorWashington University School of Medicine

Started2026-08-01

View on ClinicalTrials.gov ↗

The purpose of this study is to find out which pain medication is more effective in reducing pain after nose surgery (rhinoplasty). The investigators are looking to find the best treatment to reduce discomfort and improve the healing process for patients having nose surgery.

Amendment history 1 change detected by DataLookout

2026-08-19

Recruitment opened

Trial Details

NCT Number	NCT07689162
Lead Sponsor	Washington University School of Medicine
Conditions	Pain, Postoperative
Enrollment	45 participants
Start Date	2026-08-01
Primary Completion	2027-06 (estimated)
Study Completion	2027-07 (estimated)
Updated on ClinicalTrials.gov	2026-08-18